at-home testing
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
The company offers an at-home test where a breath sample is collected and analyzed by trained dogs and AI to detect early-stage cancer.
Curai Health will provide virtual care to participants to help researchers compare the accuracy of at-home tests with PCR lab tests in detecting current COVID-19 and influenza strains.